Target intelligence / Profile preview

Immune system cells and inflammatory microenvironment via paracrine factors and cell–cell contact

Molecular classification
Other
01

Overview

The immune system cells and inflammatory microenvironment represent a complex network of interactions between various leukocytes, stromal cells, and the extracellular matrix. These interactions are mediated by paracrine factors, such as cytokines and chemokines, and direct cell-cell contact via surface receptors. Paracrine signaling allows for rapid communication and recruitment of immune cells to sites of injury or malignancy (Grivennikov et al., Cell, 2010). Cell-cell contact, particularly through immune checkpoints like PD-1/PD-L1, provides critical regulatory signals that can either activate or exhaust immune responses (Binnewies et al., Nature Medicine, 2018). In oncology, this microenvironment is often hijacked to create an immunosuppressive niche that facilitates tumor growth and evasion of the immune system (Pitt et al., Annals of Oncology, 2016). In autoimmune and chronic inflammatory diseases, dysregulated signaling within this environment leads to persistent tissue damage. Therapeutic strategies aim to reprogram this environment by blocking inhibitory signals or neutralizing pro-inflammatory factors (Pardoll, Nature Reviews Cancer, 2012). While not a single molecular target, this system is the primary focus of modern immunotherapies and anti-inflammatory agents.

Other names
Inflammatory microenvironmentTumor microenvironmentImmune nicheParacrine inflammatory signalingImmune-stromal interactome
02

Mechanism of action

Modulation of the inflammatory milieu through inhibition of cytokines or checkpoint receptors to restore immune homeostasis or enhance anti-tumor activity.

03

Biological functions

Immune responseCell-cell communicationInflammationSignal transductionCell recruitment
04

Disease associations

CancerInflammationAutoimmune diseaseInfection
05

Safety considerations

Cytokine release syndrome (CRS)Immune-related adverse events (irAEs)Systemic immunosuppressionAutoimmunity
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

Programmed death-ligand 1 (PD-L1) expressionTumor-infiltrating lymphocytes (TILs)C-reactive protein (CRP)Cytokine profiles (e.g., IL-6, TNF-alpha)Soluble CD25

Beyond the preview

Go deeper on Immune system cells and inflammatory microenvironment via paracrine factors and cell–cell contact.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system cells and inflammatory microenvironment via paracrine factors and cell–cell contact.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call